Stroke-CORE: master study protocol of the national cohort of the specialty network stroke within the network university medicine in Germany
Authors:
- Flora Noelle WiegandFWFlora Noelle Wiegand
- Angelika AlonsoAAAngelika Alonso
- Heinrich J. AudebertHAHeinrich J. Audebert
- Jessica BarlinnJBJessica Barlinn
- Martin BendszusMBMartin Bendszus
- Folke BrinkmannFolke Brinkmann
- Bastian ChengBCBastian Cheng
- Mark DzietkoMark Dzietko
- Katharina FeilKFKatharina Feil
- Agnes FlöelAFAgnes Flöel
- Christina FranzisketCFChristina Franzisket
- Lucia GerstlLGLucia Gerstl
Open Access
- 30 October 2026
- journal article
- research article
- Published by Springer Nature in Neurological Research and Practice
- Vol. 8 (1) , 92
Abstract
Introduction: Although Germany has a strong history of stroke research, it currently lacks a national harmonised infrastructure for clinical stroke research. To address this gap, the stroke-specific Specialty Network (SN Stroke) of the Network University Medicine (NUM) was established as a comprehensive research platform. Hereby we present the protocol of the Stroke-CORE cohort (COhort for REsearch in Stroke) within SN Stroke enrolling a large representative cohort of patients with acute ischeamic stroke or intracerebral haemorrhage in Germany. Methods: Stroke-CORE is a national, prospective, longitudinal, multi-centre cohort study with a decentralised biobank, structured as a modular umbrella protocol. Adult patients with acute ischaemic stroke or intracerebral haemorrhage, and paediatric stroke patients are enrolled at participating hospitals. Data collection follows four adaptive levels, ranging from a core clinical data set (Level 1) to modules covering the whole stroke care pathway (Level 2), biosamples (Level 3), and voluntary additional modules (Level 4), with follow-up at discharge, 90 days, 180 days (optional), and annually. Enrolment started in August 2026 across 12 initial sites, with a target of 12,750 patients being recruited by 2030. Perspective: Stroke-CORE represents a nationally harmonised cohort spanning prehospital care, acute treatment, rehabilitation, prevention, aftercare, and paediatric stroke. Its adaptive modular design allows continuous expansion with new modules, data streams, and biobanking initiatives without protocol revision. As a sustainable national research platform, Stroke-CORE aims to address key knowledge gaps, facilitate recruitment for clinical trials, and accelerate translational, clinical and outcomes research. Trial registration: The protocol is registered at German Clinical Trials Register (DRKS00039775, July 8th, 2026).Keywords
Funding Information
- Universitätsklinikum Würzburg
This publication has 23 references indexed in Scilit:
- National standardisierter Broad Consent in der Praxis: erste Erfahrungen, aktuelle Entwicklungen und kritische BetrachtungenBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2024
- Efficacy and safety of transcranial direct current stimulation to the ipsilesional motor cortex in subacute stroke (NETS): a multicenter, randomized, double-blind, placebo-controlled trialThe Lancet Regional Health - Europe, 2024
- Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trialThe Lancet, 2023
- Data protection-compliant broad consent for secondary use of health care data and human biosamples for (bio)medical research: Towards a new German national standardJournal of Biomedical Informatics, 2022
- Association Between Dispatch of Mobile Stroke Units and Functional Outcomes Among Patients With Acute Ischemic Stroke in BerlinJAMA, 2021
- Prevalence and Determinants of Systolic and Diastolic Cardiac Dysfunction and Heart Failure in Acute Ischemic Stroke Patients: The SICFAIL StudyESC Heart Failure, 2020
- A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trialThe Lancet Neurology, 2020
- Health Care Costs of Spontaneous Aneurysmal Subarachnoid Hemorrhage for Rehabilitation, Home Care, and In-Hospital Treatment for the First YearWorld Neurosurgery, 2017
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trialsThe Lancet, 2016
- Cost of atherothrombotic diseases—myocardial infarction, ischaemic stroke and peripheral arterial occlusive disease—in GermanyJournal of Public Health, 2005